EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Epidemiological evidence for the role of puberty and immune senescence in Hodgkin lymphoma aetiology from 1992 Danish cases

Klaus Rostgaard iD, Stephen Hamilton-Dutoit, Kristina L Lauridsen, Lisa Ottander, Trine L Plesner, Peter Hollander, Peter Brown iD, Lene Sjö, Christoffer Johansen iD, Peter Kamper, Estrid Høgdall iD, Francesco d'Amore und 7 weitere

International Journal of Cancer · 2025

DOI: 10.1002/ijc.70305 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer, 2025. Verfasst von Klaus Rostgaard und 18 weiteren Autor:innen. Beteiligte Einrichtung: Danish Cancer Institute, Danish Cancer Society, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Hodgkin Disease, Puberty, Immunosenescence. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Danmarks Frie Forskningsfond, Kræftens Bekæmpelse, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Current epidemiological thinking is that classic Hodgkin lymphoma (cHL) comprises multiple aetiologically distinct disease entities that may in part be defined by either histological subtype or the presence of Epstein–Barr virus (EBV) in the malignant cells, or by both. This study aimed to advance our understanding of epidemiological differences between cHL subtypes, in particular EBV‐positive and EBV‐negative cHL. We retrospectively collected and EBV‐typed 1992 cHL primary tumour tissues from among all 2811 patients diagnosed with incident HL in Denmark in the period 1990 through 2010 ‘Hodgkin lymphoma in Denmark’ [HOLYDAN] project. Based on characteristics of retrieved samples combined with additional information from national registers, we projected nationwide age‐, sex‐, histology‐ and EBV‐specific cHL incidence rates. The analyses demonstrated age‐ and sex‐dependent variation in histology‐ and EBV‐tumour status‐specific cHL incidence rates, details of which yielded new aetiological clues. cHL incidence increased markedly around the age of puberty, irrespective of histological subtype and EBV status. The incidence of all subtypes of cHL increased with age after age 50 years, with the exception of EBV‐negative nodular sclerosis cHL in females, which therefore showed a single peak in incidence and was higher than in males among young adults. These results were obtained in a small homogeneous population and might, therefore, only apply to rich, industrialised, Western populations. Nevertheless, we propose that puberty creates an immunological host environment conducive to cHL development irrespective of EBV status and histology, and that age‐related decline in immune function facilitates the development of both EBV‐positive and EBV‐negative cHL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hodgkin DiseasePubertyImmunosenescenceHumansFemaleMaleDenmarkAdultMiddle AgedAdolescentEpstein-Barr Virus InfectionsYoung AdultIncidenceChildHerpesvirus 4, HumanAgedRetrospective StudiesChild, Preschool

Stichwörter der Autor:innen

Epstein–Barr virusHodgkin lymphomaaetiologyimmune senescencepuberty

Autor:innen und Institutionen

  • Danish Cancer Institute, Danish Cancer Society, Copenhagen, Denmark.
  • Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.
  • Department of Pathology, Aarhus University Hospital, Aarhus, Denmark.
  • Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
  • Department of Pathology, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark.
  • Department of Haematology, University Hospital of Copenhagen, Copenhagen, Denmark.

ORCID-Profile: Klaus Rostgaard, Peter Brown, Christoffer Johansen, Estrid Høgdall, Martin Hutchings, Ingrid Glimelius, Henrik Hjalgrim

Förderung

  • Danmarks Frie Forskningsfond
  • Kræftens Bekæmpelse
  • NIH HHS
  • Børnecancerfonden
  • Cancerfonden
  • National Institutes of Health

Zitieren

APA

Rostgaard, K., Hamilton-Dutoit, S., Lauridsen, K. L., Ottander, L., Plesner, T. L., Hollander, P., Brown, P., Sjö, L., Johansen, C., Kamper, P., Høgdall, E., d'Amore, F., Specht, L., Jarrett, R. F., McKay, J. D., Hutchings, M., Hjalgrim, L. L., Glimelius, I., & Hjalgrim, H. (2025). Epidemiological evidence for the role of puberty and immune senescence in Hodgkin lymphoma aetiology from 1992 Danish cases. International Journal of Cancer. https://doi.org/10.1002/ijc.70305

Vancouver

Rostgaard K, Hamilton-Dutoit S, Lauridsen KL, Ottander L, Plesner TL, Hollander P, et al. Epidemiological evidence for the role of puberty and immune senescence in Hodgkin lymphoma aetiology from 1992 Danish cases. International Journal of Cancer. 2025. doi:10.1002/ijc.70305

BibTeX
@article{Rostgaard2025,
  author = {Rostgaard, Klaus and Hamilton-Dutoit, Stephen and Lauridsen, Kristina L and Ottander, Lisa and Plesner, Trine L and Hollander, Peter and Brown, Peter and Sjö, Lene and Johansen, Christoffer and Kamper, Peter and Høgdall, Estrid and d'Amore, Francesco and Specht, Lena and Jarrett, Ruth F and McKay, James D and Hutchings, Martin and Hjalgrim, Lisa L and Glimelius, Ingrid and Hjalgrim, Henrik},
  title = {Epidemiological evidence for the role of puberty and immune senescence in Hodgkin lymphoma aetiology from 1992 Danish cases},
  journal = {International Journal of Cancer},
  year = {2025},
  doi = {10.1002/ijc.70305}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche